Literature DB >> 25976202

Quetiapine-induced hypertriglyceridaemia causing acute pancreatitis.

John Mark Franco1, Saraschandra Vallabhajosyula1, Timothy John Griffin2.   

Abstract

Second-generation antipsychotics have well-known metabolic side effects such as hyperlipidaemia and hyperglycaemia. A middle-aged man presented with epigastric and flank pain associated with nausea, and was noted to have elevated triglycerides (3590 mg/dL or 40.53 mmol/L), lipase and glucose. Haematological parameters revealed neutropenia with pancytopaenia. The patient was started on conservative management for acute pancreatitis, and on intravenous insulin and oral gemfibrozil for lowering of his triglycerides. He gradually improved and was transitioned to oral atorvastatin and fenofibrate. His triglycerides, glucose and leucocyte counts normalised at discharge and he was transitioned to ziprasidone. The combination of hypertriglyceridaemia, worsening hyperglycaemia and neutropenia made us suspect quetiapine as the causative agent. Medications cause only 0.1-7% of acute pancreatitis cases, with quetiapine implicated in only five-reported cases. Hypertriglyceridaemia (>600 mg/dL or 6.77 mmol/L) is frequently reported with quetiapine use, but severe hypertriglyceridaemia (>1000 mg/dL or 11.29 mmol/L) has been reported in <10 patients. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25976202      PMCID: PMC4434332          DOI: 10.1136/bcr-2015-209571

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Hypertriglyceridemia-Induced Pancreatitis in Psychiatric Patients: A Case Report and Review of Literature.

Authors:  Yaseen Alastal; Syed Hasan; Mohammed A Chowdhury; Tariq Hammad; Fadi Safi; Daniel Rapport; Ragheb Assaly
Journal:  Am J Ther       Date:  2016 May-Jun       Impact factor: 2.688

2.  Quetiapine treatment in youth is associated with decreased insulin secretion.

Authors:  Ying Fai Ngai; Paul Sabatini; Duc Nguyen; Jana Davidson; Jean-Pierre Chanoine; Angela M Devlin; Francis C Lynn; Constadina Panagiotopoulos
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

3.  Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.

Authors:  Chun-Yuan Lin; Guochuan E Tsai; Hong-Song Wang; Yu-Hsin Wu; Chin-Chih Chiou; Vivian Y Wu; Hsien-Yuan Lane
Journal:  J Clin Psychiatry       Date:  2014-09       Impact factor: 4.384

4.  A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test.

Authors:  Chun-Hsin Chen; Tsang-Yaw Lin; Tzu-Ting Chen; Vincent Chin-Hung Chen; Ni-Chi Lin; Wen-Chuan Shao; Mong-Liang Lu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-02-01       Impact factor: 5.067

5.  Quetiapine-induced neutropenia in a bipolar patient with hepatocellular carcinoma.

Authors:  Han-Ching Tang; Kuo-Hsuan Chung
Journal:  Int J Psychiatry Med       Date:  2014       Impact factor: 1.210

Review 6.  Severe hypertriglyceridemia-related acute pancreatitis.

Authors:  Claudia Stefanutti; Giancarlo Labbadia; Claudia Morozzi
Journal:  Ther Apher Dial       Date:  2013-02-28       Impact factor: 1.762

7.  A case with neutropenia related with the use of various atypical antipsychotics.

Authors:  Myung Ho Lim; Jong-Il Park; Tae Won Park
Journal:  Psychiatry Investig       Date:  2013-12-16       Impact factor: 2.505

8.  Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.

Authors:  Gabrielle Crépeau-Gendron; Sophie L'Heureux
Journal:  Early Interv Psychiatry       Date:  2014-04-01       Impact factor: 2.732

9.  Pancreatitis and diabetic ketoacidosis with quetiapine use.

Authors:  Javaid Rashid; Perry J Starer; Shazia Javaid
Journal:  Psychiatry (Edgmont)       Date:  2009-05

10.  Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).

Authors:  Eric D A Hermes; Daniel Sokoloff; T Scott Stroup; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

View more
  1 in total

Review 1.  Is It Possible to Predict the Future in First-Episode Psychosis?

Authors:  Jaana Suvisaari; Outi Mantere; Jaakko Keinänen; Teemu Mäntylä; Eva Rikandi; Maija Lindgren; Tuula Kieseppä; Tuukka T Raij
Journal:  Front Psychiatry       Date:  2018-11-13       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.